AGA clinical practice update on de-prescribing of proton pump inhibitors: expert review

LE Targownik, DA Fisher, SD Saini - Gastroenterology, 2022 - Elsevier
Description Proton pump inhibitors (PPIs) are among the most commonly used medications
in the world. Developed for the treatment and prevention of acid-mediated upper …

Clostridium difficile Infection

DA Leffler, JT Lamont - New England Journal of Medicine, 2015 - Mass Medical Soc
This article reviews the pathogenesis, epidemiology, diagnosis, and treatment of this
nosocomial and potentially fatal infectious diarrhea, as well as the associated risk factors …

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for …

LC McDonald, DN Gerding, S Johnson… - Clinical infectious …, 2018 - academic.oup.com
Triptolide (TP), a traditional Chinese medicine, has been reported to be effective in the
treatment of autoimmune diseases and exerting antineoplastic activity in several human …

Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin

P Moayyedi, JW Eikelboom, J Bosch, SJ Connolly… - Gastroenterology, 2019 - Elsevier
Background & Aims Proton pump inhibitors (PPIs) are effective at treating acid-related
disorders. These drugs are well tolerated in the short term, but long-term treatment was …

[HTML][HTML] Global burden of Clostridium difficile infections: a systematic review and meta-analysis

E Balsells, T Shi, C Leese, I Lyell, J Burrows… - Journal of global …, 2019 - ncbi.nlm.nih.gov
Background Clostridium difficile is a leading cause of morbidity and mortality in several
countries. However, there are limited evidence characterizing its role as a global public …

Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study

KG Blumenthal, N Lu, Y Zhang, Y Li, RP Walensky… - bmj, 2018 - bmj.com
Objective To evaluate the relation between penicillin allergy and development of meticillin
resistant Staphylococcus aureus (MRSA) and C difficile. Design Population based matched …

[HTML][HTML] Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis

A Trifan, C Stanciu, I Girleanu, OC Stoica… - World journal of …, 2017 - ncbi.nlm.nih.gov
AIM To perform a systematic review and meta-analysis on proton pump inhibitors (PPIs)
therapy and the risk of Clostridium difficile infection (CDI). METHODS We conducted a …

Guidelines for diagnosis, treatment, and prevention ofclostridium difficileInfections

CM Surawicz, LJ Brandt, DG Binion… - Official journal of the …, 2013 - journals.lww.com
Clostridium difficileinfection (CDI) is a leading cause of hospital-associated gastrointestinal
illness and places a high burden on our health-care system. Patients with CDI typically have …

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious …

SH Cohen, DN Gerding, S Johnson… - Infection Control & …, 2010 - cambridge.org
Since publication of the Society for Healthcare Epidemiology of America position paper on
Clostridium difficile infection in 1995, significant changes have occurred in the epidemiology …

Risk ofClostridium difficileInfection with acid suppressing drugs and antibiotics: Meta-analysis

CS Kwok, AK Arthur, CI Anibueze, S Singh… - Official journal of the …, 2012 - journals.lww.com
OBJECTIVES: Several studies have raised concern regarding the possible association
between proton-pump inhibitors (PPIs) andClostridium difficileinfection (CDI). We aimed to …